跳至主要内容
临床试验/NCT01120730
NCT01120730已完成3 期

Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury

University of Zurich1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 1997年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
28
试验地点
1
主要终点
Intensive care unit mortality

研究概览

简要总结

HES 200/0.5 10% is equal to ringers lactat solution.

详细描述

30 Patients were enrolled to the study, either to the hyperoncotic HES 200/0.5 (10%) group or to the crystalloids only group. After a treatment protocol of 72 hours we collected data about complications like pulmonary failure and abdominal compartment syndrome. Furthermore, we addressed the question of incidence of mortality and renal failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All burn victims with burned surface area bigger than 20%

排除标准

  • Pregnancy

研究组 & 干预措施

HES

Active Comparator

Fluid resuscitation with HES

干预措施: Fluid resuscitation (Drug)

ringers lactat

Placebo Comparator

Standard treatment

干预措施: Fluid resuscitation (Drug)

结局指标

主要结局

Intensive care unit mortality

时间窗: 28 days

28 days

次要结局

  • fluid amount during the first 72 hours(28 days)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Fluid Resuscitation With HES 200/0.5 10% in Severe... | 临床试验